290 related articles for article (PubMed ID: 2996353)
21. HTLV-III infection in Canada in 1985.
Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
Yarchoan R; Redfield RR; Broder S
J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
[TBL] [Abstract][Full Text] [Related]
23. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
[TBL] [Abstract][Full Text] [Related]
24. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
[TBL] [Abstract][Full Text] [Related]
26. [Human T-lymphotropic retrovirus and AIDS. HTLV-III is probably the cause of acquired immunodeficiency syndrome].
Dobloug JH
Tidsskr Nor Laegeforen; 1985 Jan; 105(1):50-2. PubMed ID: 2982219
[No Abstract] [Full Text] [Related]
27. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
28. Clinical spectrum of HTLV-III in humans.
Groopman JE
Cancer Res; 1985 Sep; 45(9 Suppl):4649s-4651s. PubMed ID: 2990701
[TBL] [Abstract][Full Text] [Related]
29. Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome.
Sarngadharan MG; Schüpbach J; Bruch L; Devico A; Markham PD; Wong-Staal F; Gallo RC
Prog Clin Biol Res; 1985; 182():309-27. PubMed ID: 2994105
[No Abstract] [Full Text] [Related]
30. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
31. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
Ory HW; Koplan JP; Allen JR
Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
[TBL] [Abstract][Full Text] [Related]
32. The Walter Reed staging classification for HTLV-III/LAV infection.
Redfield RR; Wright DC; Tramont EC
N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
[TBL] [Abstract][Full Text] [Related]
33. [HTLV-III in persons with intravenous drug abuse. Correlation of antibodies against HTLV-III with neopterin and TH/TS].
Hengster P; Blecha HG; Deinhardt F; Erfle V; Fuchs D; Goebel FD; Gürtler LG; Hausen A; Hinterhuber H; Reibnegger G
Dtsch Med Wochenschr; 1986 Mar; 111(12):453-7. PubMed ID: 3004878
[TBL] [Abstract][Full Text] [Related]
34. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R
Blood; 1985 Sep; 66(3):742-4. PubMed ID: 2992644
[TBL] [Abstract][Full Text] [Related]
35. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
36. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
[TBL] [Abstract][Full Text] [Related]
37. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
[TBL] [Abstract][Full Text] [Related]
38. [A simple method for determination of antibodies to AIDS associated virus (HTLV-III)].
Biberfeld G; Bredberg-Rådén U; Böttiger B; Biberfeld P; Morfeldt-Månsson L; Suni J; Vaheri A; Saxinger C; Gallo R
Lakartidningen; 1984 Sep; 81(39):3482-3. PubMed ID: 6092800
[No Abstract] [Full Text] [Related]
39. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Dec; 34(48):721-6, 731-2. PubMed ID: 2999576
[TBL] [Abstract][Full Text] [Related]
40. The human T-cell leukemia/lymphotropic retroviruses (HTLV) family: past, present, and future.
Gallo RC
Cancer Res; 1985 Sep; 45(9 Suppl):4524s-4533s. PubMed ID: 2990681
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
